Arthur Daemmrich came to the Institute as a research fellow for two consecutive years. In 2000–2001 his project was titled “Pharmaceutical Regulation: The Science and Politics of Health in the United States and Germany.” The next year his focus was “Corporate Governance: Changing Relations among Science-Based Industry, States, and the Public.”